Supernus to Seek FDA Approval of Infusion Pump Device
Supernus Pharmaceuticals plans to resubmit its application seeking approval of SPN-830, its apomorphine infusion pump for people with Parkinson’s disease, to the FDA by the end of this year.
Read More